Nurses' Physical and Psychological Symptoms During the first COVID-19 Lockdown in Italy: a Nationwide Cross-Sectional Study in Stem Cell Transplantation Setting.

Burnout COVID-19 Hematopoietic stem cell transplantation Nurse Pandemic Sleep disorders

Journal

Mediterranean journal of hematology and infectious diseases
ISSN: 2035-3006
Titre abrégé: Mediterr J Hematol Infect Dis
Pays: Italy
ID NLM: 101530512

Informations de publication

Date de publication:
2022
Historique:
received: 12 10 2021
accepted: 14 12 2021
entrez: 24 1 2022
pubmed: 25 1 2022
medline: 25 1 2022
Statut: epublish

Résumé

Northern Italy was one of the first European territories to deal with the Coronavirus Disease 2019 (COVID-19) outbreak. Drastic emergency restrictions were introduced to contain the spread and limit pressure on healthcare facilities. However, nurses were at high risk of developing physical, mental, and working issues due to professional exposure. The aim of this cross-sectional study was to investigate these issues among nurses working in Italian hematopoietic stem cell transplant (HSCT) centers during the COVID-19 pandemic. Data were collected online immediately after the first "lockdown" period in order to investigate the prevalence of physical issues, sleep disorders, and burnout symptoms and explore correlations with COVID-19 territorial incidence in Northern Italian regions versus Central and Southern Italian regions. Three hundred and eight nurses working in 61 Italian HSCT Units responded to the survey. Depression, cough, and fever were more frequently reported by nurses working in geographical areas less affected by the pandemic (p=0.0013, p<0.0001, and p=0.0005 respectively) as well as worst sleep quality (p=0.008). Moderate levels of emotional exhaustion (mean±SD -17.4±13.0), depersonalization (5.3±6.1), and personal accomplishment (33.2±10.7) were reported without significant differences between territories. different COVID-19 incidence among territories did not influence nurses' burden of symptoms in the HSCT setting. However, burnout and insomnia levels should be considered by health care facilities in order to improve preventive strategies.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Northern Italy was one of the first European territories to deal with the Coronavirus Disease 2019 (COVID-19) outbreak. Drastic emergency restrictions were introduced to contain the spread and limit pressure on healthcare facilities. However, nurses were at high risk of developing physical, mental, and working issues due to professional exposure. The aim of this cross-sectional study was to investigate these issues among nurses working in Italian hematopoietic stem cell transplant (HSCT) centers during the COVID-19 pandemic.
METHODS METHODS
Data were collected online immediately after the first "lockdown" period in order to investigate the prevalence of physical issues, sleep disorders, and burnout symptoms and explore correlations with COVID-19 territorial incidence in Northern Italian regions versus Central and Southern Italian regions.
RESULTS RESULTS
Three hundred and eight nurses working in 61 Italian HSCT Units responded to the survey. Depression, cough, and fever were more frequently reported by nurses working in geographical areas less affected by the pandemic (p=0.0013, p<0.0001, and p=0.0005 respectively) as well as worst sleep quality (p=0.008). Moderate levels of emotional exhaustion (mean±SD -17.4±13.0), depersonalization (5.3±6.1), and personal accomplishment (33.2±10.7) were reported without significant differences between territories.
CONCLUSIONS CONCLUSIONS
different COVID-19 incidence among territories did not influence nurses' burden of symptoms in the HSCT setting. However, burnout and insomnia levels should be considered by health care facilities in order to improve preventive strategies.

Identifiants

pubmed: 35070217
doi: 10.4084/MJHID.2022.010
pii: mjhid-14-1-e2022010
pmc: PMC8747087
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2022010

Déclaration de conflit d'intérêts

Conflict of interest: The authors declare no conflict of Interest.

Références

JAMA Psychiatry. 2020 Oct 1;77(10):989-990
pubmed: 32275289
World Psychiatry. 2020 Jun;19(2):261
pubmed: 32394565
Bull Math Biol. 2020 Jan 14;82(1):14
pubmed: 31932981
World Psychiatry. 2020 Jun;19(2):129-130
pubmed: 32394569
Eur Psychiatry. 2020 Apr 01;63(1):e32
pubmed: 32234102
J Anxiety Disord. 2020 Aug;74:102268
pubmed: 32650221
J Pain Symptom Manage. 2020 Jul;60(1):80-86.e2
pubmed: 32105789
Med Hypotheses. 2020 Nov;144:109972
pubmed: 32531540
Arch Acad Emerg Med. 2020 Dec 10;9(1):e7
pubmed: 33490964
Br J Cancer. 2008 Mar 25;98(6):1046-52
pubmed: 18283310
J Gen Intern Med. 2021 May;36(5):1319-1326
pubmed: 33694071
Arch Iran Med. 2020 Apr 01;23(4):268-271
pubmed: 32271601
Psychother Psychosom. 2000 Nov-Dec;69(6):329-34
pubmed: 11070446
Saf Sci. 2022 Jan;145:105499
pubmed: 34545269
J Family Med Prim Care. 2020 Dec 31;9(12):5921-5926
pubmed: 33681020
Assist Inferm Ric. 2016 Jan-Mar;35(1):6-15
pubmed: 27183420
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Psychiatr Danub. 2020 Spring;32(1):3-5
pubmed: 32303022
PLoS One. 2020 Dec 28;15(12):e0244630
pubmed: 33370404
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
BMC Psychiatry. 2021 Mar 16;21(1):152
pubmed: 33726704
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
Semin Oncol Nurs. 2020 Jun;36(3):151028
pubmed: 32423833
J Pain Symptom Manage. 2020 Jul;60(1):e60-e65
pubmed: 32283221
Psychol Health Med. 2022 Jan;27(1):186-198
pubmed: 33378219
J Pain Symptom Manage. 2021 Feb;61(2):e4-e12
pubmed: 33249082
Neurol Sci. 2013 Apr;34(4):511-9
pubmed: 22526760
PLoS One. 2020 Jan 6;15(1):e0226483
pubmed: 31905206
BJPsych Open. 2021 Jan 07;7(1):e27
pubmed: 33407989
JMIR Public Health Surveill. 2020 Dec 22;6(4):e24206
pubmed: 33284784
Med Sci Monit. 2020 Apr 15;26:e924171
pubmed: 32291383
Prev Med Rep. 2021 Dec;24:101518
pubmed: 34458081
Front Psychol. 2020 Oct 08;11:2179
pubmed: 33117208
Int J Environ Res Public Health. 2020 Nov 12;17(22):
pubmed: 33198084
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030
Eur Psychiatry. 2021 Apr 26;64(1):e32
pubmed: 33971992
World Psychiatry. 2020 Jun;19(2):130-131
pubmed: 32394549
Hum Factors. 2020 Nov;62(7):1061-1068
pubmed: 32648781
Psychiatry Res. 2020 Aug;290:113129
pubmed: 32485487
BJPsych Open. 2020 Dec 29;7(1):e24
pubmed: 33371927
Ann Med. 2021 Dec;53(1):189-196
pubmed: 33307858
Eur Psychiatry. 2020 May 20;63(1):e45
pubmed: 32431255
J Clin Nurs. 2021 Feb;30(3-4):397-405
pubmed: 33141987
World Psychiatry. 2020 Oct;19(3):406-407
pubmed: 32931089
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Arch Intern Med. 2012 Oct 8;172(18):1377-85
pubmed: 22911330
J Clin Nurs. 2020 Aug;29(15-16):2762-2764
pubmed: 32344460
Eur Psychiatry. 2020 Sep 28;63(1):e87
pubmed: 32981568
Eur Psychiatry. 2021 Feb 15;64(1):e15
pubmed: 33583453
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Postgrad Med J. 2020 Jun;96(1136):367-368
pubmed: 32457131
J Clin Nurs. 2021 May;30(9-10):1360-1371
pubmed: 33534934
World J Clin Cases. 2020 Apr 26;8(8):1391-1399
pubmed: 32368532
Lancet Haematol. 2020 Oct;7(10):e737-e745
pubmed: 32798473
Front Med. 2020 Apr;14(2):117-125
pubmed: 32318975
J Psychosom Res. 2021 Feb;141:110343
pubmed: 33360329
Mediterr J Hematol Infect Dis. 2021 Jan 01;13(1):e2021011
pubmed: 33489050

Auteurs

Stefano Botti (S)

Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, viale Risorgimento 80, 42123, Reggio Emilia, Italy.

Chiara Cannici (C)

Division of Hematology, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, via Venezia 16, 15121, Alessandria, Italy.

Sarah Jayne Liptrott (SJ)

Ente Ospedaliero Cantonale, Via Ospedale, Bellinzona, Switzerland.

Valentina De Cecco (V)

Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital IRCCS, Piazza Sant'Onofrio 4, 00165, Rome, Italy.

Elena Rostagno (E)

Oncoematologia Pediatrica, IRCCS Azienda Ospedaliero Universitaria di Bologna, via Giuseppe Massarenti 13, 40138, Bologna, Italy.

Gianpaolo Gargiulo (G)

Haematology Unit, Federico II University Hospital of Naples, via S. Pansini 5, 80131, Naples, Italy.

Laura Orlando (L)

Istituto Oncologico della Svizzera Italiana, via A. Gallino 12, 6500, Bellinzona, Switzerland.

Alessandro Caime (A)

Division of Hemato-Oncology, European Institute of Oncology IRCCS, via Ripamonti 435, 20141, Milan, Italy.

Emanuela Samarani (E)

Unit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili, Piazzale Spedali Civili 1, 25100, Brescia, Italy.

Letizia Galgano (L)

Transfusion Medicine and Cell Therapies, AOU-Careggi, Largo Brambilla 3, 50139, Firenze, Italy.

Marco Cioce (M)

Hematology and Trasplant Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.

Nicola Mordini (N)

Hematology Division, AO S. Croce e Carle, via M. Coppino 26, 12100 Cuneo, Italy.

Nadia Elisa Mandelli (NE)

Department of Pediatrics, University of Milano-Bicocca Fondazione MBBM/ASST, via Pergolesi 33, 20900 Monza, Italy.

Lucia Tombari (L)

Hematology and Stem Cell Transplant Center, Azienda Ospedaliera Ospedali Riuniti Marche Nord (AORMN), piazzale Carlo Cinelli 4, 61121 Pesaro, Italy.

Sara Errichiello (S)

Hematology Unit, Azienda Sanitaria Universitaria Friuli Centrale, piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.

Nicola Celon (N)

Pediatric Onco-hematology Unit, AOU Padova, via Giustiniani 2, 35128, Padova, Italy.

Roberto Lupo (R)

Emergency Unit, ASL Lecce "San Giuseppe da Copertino" Hospital, via Carmiano 1, 73043, Copertino Lecce, Italy.

Teresa Rea (T)

Department of Public Health, University Federico II of Naples, via S. Pansini 5, 80131, Naples, Italy.

Nicola Serra (N)

Department of Public Health, University Federico II of Naples, via S. Pansini 5, 80131, Naples, Italy.

Classifications MeSH